"Willkommen im Vivantes Humboldt-Klinikum in Berlin-Reinickendorf – Ihrem Klinikum auf nationalem Spitzenniveau in Medizin und Technologie. Mit viel Empathie und einem berlinweit führenden Service und Komfortangebot sorgen wir für Ihre Gesundheit und Ihr Wohlergehen."

During the past decade, Vivantes Humboldt Klinikum conducted 14 clinical trials. In the 10-year time frame, 14 clinical trials started and 4 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 3 clinical trials were completed. i.e. 37.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vivantes Humboldt Klinikum" #1 sponsor was "Biotronik SE & Co. KG" with 4 trials, followed by "Charite University, Berlin, Germany" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Aesculap AG" with 1 trials sponsored and "Angle plc" with 1 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vivantes Humboldt Klinikum" #1 collaborator was "Charite University, Berlin, Germany" with 2 trials as a collaborator, "Abbott" with 1 trials as a collaborator, "Aesculap, Inc." with 1 trials as a collaborator, "BARMER" with 1 trials as a collaborator and "Boston Scientific Corporation" with 1 trials as a collaborator. Other collaborators include 17 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "Vivantes Humboldt Klinikum" are "Congestive Heart Failure" (2 trials), "Heart Failure" (2 trials), "Myocardial Infarction" (2 trials), "Ventricular Fibrillation" (2 trials) and "Ventricular Tachycardia" (2 trials). Many other conditions were trialed in "Vivantes Humboldt Klinikum" in a lesser frequency.

Most popular intervention types in "Vivantes Humboldt Klinikum" are "Device" (7 trials), "Drug" (6 trials), "Other" (4 trials), "Behavioral" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Prehabilitation- new form of care" (2 trials), "7-day Holter ECG" (1 trials), "BioMonitor" (1 trials) and "Blood draw" (1 trials). Other intervention names were less common.

The vast majority of trials in "Vivantes Humboldt Klinikum" are 18 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Vivantes Humboldt Klinikum". 1 are not yet recruiting, 4 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Vivantes Humboldt Klinikum, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Vivantes Humboldt Klinikum, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".